Also trades as: 603127.SS (SHH) · $vol 296M

HK$30.42 ($3.88)

-0.38 (-1.23%)

Weekly Expected Move ±10.8%

HK$24 HK$27 HK$30 HK$34 HK$37

HKSE · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 67 · HK$41.7B mcap · 486M float · 1.39% daily turnover

Revenue

$2.0B -15.1% ▼

5Y CAGR: +25.8%

Gross Profit

$574M -43.3% ▼

5Y CAGR: +11.3%

Operating Income

$104M -79.4% ▼

5Y CAGR: -12.7%

Net Income

$74M -81.3% ▼

5Y CAGR: -16.1%

EPS (Diluted)

$0.10 -81.4% ▼

5Y CAGR: -19.4%

EBITDA

$234M -63.4% ▼

5Y CAGR: -1.9%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$1.1B	$1.5B	$2.3B	$2.4B	$2.0B
YoY Growth	+68.3%	+41.0%	+49.5%	+4.8%	-15.1%
Cost of Revenue	$523M	$778M	$1.2B	$1.4B	$1.4B
Gross Profit	$553M	$739M	$1.1B	$1.0B	$574M
Gross Margin	51.4%	48.7%	47.9%	42.6%	28.4%
R&D Expenses	$51M	$48M	$78M	$97M	$93M
SG&A Expenses	$98M	$113M	$96M	$101M	$119M
Operating Expenses	$251M	$287M	$369M	$506M	$469M
Operating Income	$361M	$643M	$1.2B	$507M	$104M
Operating Margin	33.6%	42.4%	54.0%	21.3%	5.2%
Interest Expense	$837K	$4M	$4M	$3M	$326K
Income Before Tax	$361M	$642M	$1.2B	$507M	$104M
Tax Expense	$47M	$86M	$167M	$115M	$34M
Net Income	$315M	$557M	$1.1B	$397M	$74M
Net Margin	29.3%	36.8%	47.4%	16.7%	3.7%
EPS (Diluted)	$0.51	$1.11	$2.00	$0.53	$0.10
EBITDA	$422M	$739M	$1.4B	$640M	$234M
Shares Outstanding	624M	500M	537M	749M	749M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$486M	$683M	$287M	$381M	$316M	$673M	$316M	$386M
Cost of Revenue	$377M	$476M	$205M	$303M	$265M	$542M	$251M	$293M
Gross Profit	$109M	$207M	$82M	$78M	$52M	$131M	$65M	$93M
Gross Margin	22.4%	30.3%	28.6%	20.6%	16.3%	19.5%	20.5%	24.1%
R&D Expenses	$23M	$22M	$23M	$20M	$20M	$24M	$19M	$21M
SG&A Expenses	$188M	-$137M	$78M	-$21M	$90M	-$116M	$73M	-$16M
Operating Expenses	$1M	$33M	$33M	$48M	$122M	-$108M	-$191M	$104M
Operating Income	$107M	$174M	$49M	$30M	-$71M	$239M	$256M	-$11M
Operating Margin	22.1%	25.5%	17.2%	8.0%	-22.3%	35.5%	81.0%	-2.8%
Interest Expense	$2M	-$4M	$0	$255K	$303K	$342K	$274K	$339K
Income Before Tax	$107M	$174M	$49M	$31M	$19M	$238M	$256M	$557M
Tax Expense	$9M	$30M	$8M	$11M	-$268K	$21M	$18M	$50M
Net Income	$99M	$144M	$41M	$20M	$20M	$217M	$238M	$507M
Net Margin	20.5%	21.1%	14.3%	5.2%	6.2%	32.3%	75.4%	131.3%
EPS (Diluted)	$0.13	$0.19	$0.05	$0.02	$0.03	$0.29	$0.32	$0.69
EBITDA	$109M	$175M	$50M	$31M	-$71M	$238M	$256M	$27M
Shares Outstanding	749M	749M	822M	822M	733M	745M	745M	733M

6127.HK HKSE